Posts filtered by tags: Takeda[x]


 

Olympics: Japan's Olympic Committee head to miss meeting - IOC

Japan's Olympic Committee chief Tsunekazu Takeda, investigated in France for suspected corruption linked to the Tokyo 2020 Olympics, will not attend an International Olympic Committee (IOC) marketing meeting this weekend, the IOC said on Thursday. The IOC said Takeda, an IOC member and head of the Olympic body's marketing commission, would not be traveling to Lausanne, Switzerland for a meeting of his own commission. "The IOC has been informed by Tsunekazu Takeda that he will not be at...
Tags: Japan, News, France, Tokyo, Ioc, Lausanne, Olympic Committee, Lausanne Switzerland, Takeda, International Olympic Committee IOC, Tsunekazu Takeda, Marketing Commission


Takeda corruption probe soils 2020 Tokyo Olympics and IOC

Takeda corruption probe soils 2020 Tokyo Olympics and International Olympic Committee            [Author: AP]
Tags: News, Ap, Tokyo, Ioc, Takeda


Takeda corruption probe sullies 2020 Tokyo Olympics and IOC

Takeda corruption probe soils 2020 Tokyo Olympics and International Olympic Committee            [Author: AP]
Tags: News, Ap, Tokyo, Ioc, Takeda


Japan Olympic official Takeda denies corruption allegations

TOKYO (AP) — Tsunekazu Takeda, the head of the Japanese Olympic Committee and a powerful IOC member, has denied corruption allegations against him concerning reported bribes paid to be awarded the rights to host the 2020 Olympics. A French prosecutor is investigating Takeda, who is reportedly linked to about $2 million in payments in 2013 […]
Tags: Japan, News, Sports, Ap, Nation, Olympics, Tokyo, Ioc, Takeda, Japanese Olympic Committee, Tsunekazu Takeda


Probe of IOC’s Takeda hangs over Tokyo Olympics

TOKYO (AP) — A month ago, Tsunekazu Takeda was warmly applauded by 1,400 Olympic dignitaries as he spoke alongside International Olympic Committee President Thomas Bach in Tokyo. A month later, the powerful IOC member and head of the Japanese Olympic Committee is fighting a corruption investigation, suspected by French investigators of authorizing the payment of […]
Tags: News, Sports, Ap, Nation, Olympics, Tokyo, Ioc, Takeda, Thomas Bach, Japanese Olympic Committee, Tsunekazu Takeda


Probe of IOC's Takeda hangs over Tokyo Olympics

One Tokyo newspaper has said a "Black Cloud" is hanging over the Tokyo Olympics as French prosecutors weigh corruption allegations against the head of the Japanese Olympic Committee.            [Author: AP]
Tags: News, Ap, Tokyo, Ioc, Takeda, Japanese Olympic Committee


IOC marketing chair from Japan investigated for corruption

PARIS (AP) — International Olympic Committee marketing chair Tsunekazu Takeda is being investigated for suspected corruption related to the 2020 Tokyo Olympics, France’s financial crimes office said Friday. The National Financial Prosecutors office said Takeda, who is also the president of the Japanese Olympic Committee, was placed under formal investigation for “active corruption” on Dec. […]
Tags: Japan, News, France, Sports, Ap, Nation, Olympics, Paris, Tokyo, Ioc, International Olympic Committee, Takeda, Japanese Olympic Committee, Tsunekazu Takeda, National Financial Prosecutors


Takeda unlikely to sell OTC drug business - CEO

Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it closes a $59 billion takeover of London-listed Shire, Chief Executive Christophe Weber said on Monday.
Tags: London, Money, businessNews, Shire, Takeda, Takeda Pharmaceutical, Christophe Weber


Healthcare deals hit an all-time record in 2018. See the 7 biggest tie-ups that could change how we buy drugs and treat diseases.

Healthcare dealmaking hit a record this year, and the transactions could reshape how we pay for our prescriptions and treat diseases. Big pharma companies, health insurers, and care providers have agreed to about $421 billion in transactions this year, according to data from Refinitiv. That's a record high, and amounts to 11 percent of all M&A this year. The tally from Refinitiv counts deals when they're announced, though not all transactions are ultimately completed. The dollar figures includ...
Tags: Japan, US, Trends, Cigna, GlaxoSmithKline, Novartis, Shire, GSK, Takeda, Refinitiv


New collaborative partnership in quest of novel antibiotics

The Global Antibiotic Research and Development Partnership, Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.
Tags: Health, Eisai, Takeda, Takeda Pharmaceutical Company Limited


Takeda and Shire shareholders back £46bn drugs takeover

Shareholders in Shire and Takeda vote in favour of creating one of the world's biggest pharma groups.
Tags: Business, Shire, Takeda


Shareholders agree to Takeda's $60bn Shire acquisition

Japanese drug giant Takeda's mammoth $60-billion takeover of Irish pharmaceuticals firm Shire has been approved by both sets of shareholders, the pair said Wednesday. The proposed purchase, worth the equivalent of 51.5 billion euros or £46 billion, represents the biggest ever foreign takeover by a Japanese firm. A group of rebel Takeda investors, including members of the founding family, had attempted to thwart the deal but were outvoted at an extraordinary shareholders' meeting held in the w...
Tags: Science, Shire, Osaka, Takeda


Takeda clears key hurdle as investors back $59 billion Shire deal

Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire, creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt.
Tags: London, Money, businessNews, Shire, Takeda, Takeda Pharmaceutical


Takeda investors back $59 billion Shire deal, but wary of debt load

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.
Tags: London, Money, businessNews, Shire, Takeda, Takeda Pharmaceutical


Takeda shareholders approve $59 billion Shire buy but are wary of debt load

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.
Tags: London, Money, businessNews, Shire, Takeda, Takeda Pharmaceutical


Takeda shareholders agree to $60 bn Shire acquisition

Shareholders at Japanese drug giant Takeda on Wednesday approved a plan to buy Irish pharmaceuticals firm Shire in a deal worth around $60 billion, the biggest foreign takeover ever by a Japanese firm. A group of rebel investors, including members of the founding family, tried to thwart the deal but were outvoted at an extraordinary shareholders' meeting held in the western city of Osaka where the company has its headquarters. The scheme was "approved as originally proposed", said a statement...
Tags: Science, Shire, Osaka, Takeda


Takeda shareholders back £46bn Shire takeover

Investor approval paves the way for Japan's largest overseas acquisition and create a global drugs giant.
Tags: Japan, News, Shire, Takeda


Takeda gets shareholder approval for £46bn Shire takeover

The move paves the way for Japan's largest overseas acquisition and would create a global drugs giant.
Tags: Japan, UK, News, Shire, Takeda


Takeda shareholders give nod for $59 billion Shire acquisition

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.
Tags: London, Money, businessNews, Shire, Takeda, Takeda Pharmaceutical


Cardiff University collaborates with Takeda to identify new treatment approaches for psychiatric disorders

Cardiff University has formed a drug discovery collaboration with Takeda Pharmaceutical Company Limited to identify new approaches for treating schizophrenia and other psychiatric disorders.
Tags: Health, Cardiff University, Takeda, Takeda Pharmaceutical Company Limited


Takeda's Shire takeover to bring $963 million fee bonanza

Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire , according to documents for the deal published on Monday.
Tags: Money, businessNews, Shire, Takeda, Takeda Pharmaceutical


Exclusive: Takeda to win EU approval for $62 billion Shire deal - sources

Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its $62-billion bid for London's Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday.
Tags: London, Money, Eu, businessNews, Shire, Takeda, Takeda Pharmaceutical


Takeda CEO confident of investor backing for $62 billion Shire deal

The boss of Japan's Takeda Pharmaceutical said on Monday he was confident of securing investor backing for its $62 billion acquisition of London-listed Shire, despite some shareholders' fears about the resulting debt burden.
Tags: Japan, London, Money, businessNews, Shire, Takeda, Takeda Pharmaceutical


Takeda hikes annual profit forecast by a third after second-quarter profit jump

Japan's Takeda Pharmaceutical Co Ltd on Wednesday boosted its annual operating profit outlook by a third after second-quarter earnings surged on strong global sales of its drugs for bowel disease and multiple myeloma.
Tags: Japan, Money, businessNews, Takeda Pharmaceutical Co Ltd, Takeda


Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.
Tags: Health, Takeda, Takeda Pharmaceutical Company Limited


Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda Pharmaceutical Company Limited today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients.
Tags: Health, Alta, Takeda, Takeda Pharmaceutical Company Limited, ALK NSCLC


Takeda gets Japanese approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker. The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the United States, Brazil and China.
Tags: Japan, Money, businessNews, Shire PLC, Fair Trade Commission, Takeda Pharmaceutical Co Ltd, Takeda, United States Brazil


Takeda gets Japan's approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.
Tags: Japan, Money, businessNews, Shire PLC, Fair Trade Commission, Takeda Pharmaceutical Co Ltd, Takeda


Morphic Nets Another $80M For Integrin Drugs & First Human Tests

Morphic Therapeutic, a startup from Harvard scientist-entrepreneur Tim Springer, has reloaded with an $80 million Series B round that should get the company to its first human tests.The round includes a number of crossover investors (including Invus and EcoR1; Novo Holdings and Omega Funds co-led the financing), which back both private and publicly traded companies. These types of rounds often lay the groundwork for an IPO, and biotechs have been going public by the bushel this year—many withou...
Tags: Deals, Startups, Ipo, Boston, Trends, Vc, Natalizumab, Harvard, Life Sciences, Editas Medicine, Takeda, Schrodinger, Moderna Therapeutics, National blog main, New York blog main, New York top stories


CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.
Tags: Health, Takeda, Takeda Pharmaceutical Company Limited, CHMP